BBX Capital's MOD Pizza to Open Its First Miami-Dade County Location in Kendall, Florida

FORT LAUDERDALE, FL—(Marketwired – April 09, 2018) – BBX Capital (“BBX Capital” or “BBX”) announced today that the grand opening of its new South Florida MOD Pizza is planned to take place on Tuesday, April 10th. The new Kendall location, in The Palms at Town & Country at 8525 Mills Drive, Unit 301, is MOD's third in South Florida. Planned hours of operation are from 10:30am to 10:00pm, every day.

In celebration of its grand opening, MOD will give a free artisan–style pizza to the first 52 guests, after which 100 percent of all proceeds from pizza sales on opening day will be donated to the Boys & Girls Clubs of Miami–Dade.

“MOD has established itself as a leader in the fast–casual pizza category by offering customers an authentic, affordable and timely dining experience,” said Jarett Levan, President of BBX Capital. “We are thrilled to introduce the '305' to MOD, and its artisan–style pizzas with 30+ toppings, one price, and the superfast MOD experience.”

MOD's individual, artisan–style pizzas are made on demand, using fresh–pressed dough and signature sauces. Customers create their own pizzas and salads, using any combination of over 30 featured toppings, or by choosing from a menu of MOD classics. The price remains the same regardless of the number of toppings. Pizzas are hand–cooked in an 800–degree oven in just minutes and salads are individually hand–tossed for each customer. The menu is rounded out with handspun milkshakes, house–made lemonades and iced teas, and local craft beers and wine.

The 3,400–square foot Kendall location includes an outdoor patio, original artwork and a hand painted mural by Miami based artist Tragek. The store also proudly displays MOD's signature “Wall of Fame,” a photo collage that pays homage to the local community and people from the MOD journey.

BBX Capital is the exclusive franchisee for the MOD Pizza brand for the state of Florida and has signed an agreement to develop up to 60 MOD locations throughout the state over the next six years. BBX currently operates MOD locations in Coral Springs, Parkland and Jacksonville.

To learn more about MOD, please visit www.modpizza.com or watch the MOD Difference Video.

About MOD Super–Fast Pizza Holdings, LLC:
MOD Pizza is a pioneer of the fast–casual pizza segment, founded in Seattle in 2008 by entrepreneur husband and wife team Scott and Ally Svenson. MOD's individual artisan–style pizzas are made on demand, allowing customers to create their own pizzas and salads, using fresh–pressed dough, signature sauces and over 30 toppings, all for one incredible price. With more than 325 locations system–wide across 27 states and the United Kingdom, MOD is committed to creating not only a cool place to eat, but an inspired place to work. The company was recently recognized as the number one mid–sized restaurant chain in the US in the October 2017 Fishbowl Buzz Brands Report, named as the most loved pizza brand by Foodable Network in its May 2017 Most Loved Brands Report, has been ranked as America's fastest growing chain restaurant by Technomic, earned a spot on the Inc.500 list, and was recognized by Fortune as one of the “20 Best Workplaces in Retail,” a “Best Workplace for Women,” a “Best Workplace for Millennials,” and a “Best Workplace for Diversity.” For more information, please visit www.modpizza.com or connect with the brand via Facebook, Twitter or Instagram.

About BBX Capital Corporation: BBX Capital Corporation (NYSE: BBX) (OTCQX: BBXTB), is a Florida–based diversified holding company whose activities include its 90 percent ownership interest in Bluegreen Vacations Corporation (NYSE: BXG) as well as its real estate and middle market divisions. For additional information, please visit www.BBXCapital.com.

About Boys & Girls Clubs of Miami–Dade
Boys & Girls Clubs of Miami–Dade has been serving youth in the community since 1940. What once was a single building and site for boys has grown to five Clubs serving thousands of boys and girls year–round, providing programs in the areas of character and leadership development, educational enhancement, career preparation, health and life skills, cultural arts and sports, fitness and recreation. Club staffing, initiatives, and programs are designed to inspire and enable young people and provide them with the resources to succeed and share in the American Dream. For more information, please visit www.bgcmia.org.

D2L's Brightspace Offers Seven New Ways to Organize and Manage Professional Development

WATERLOO, ON—(Marketwired – April 09, 2018) – D2L today announces a Professional Development (PD) offering for Higher Education. The Brightspace learning platform can now be used to provide seven ways to organize and manage professional learning.

D2L's integrated PD offering will help customers address several industry challenges: new regulations now require instructors and staff to continue learning; faculty and staff need to acquire new skills to maintain their credentials; there is a shift away from seat–time to competency–based learning; and students are demanding to learn on smartphones and tablets so new skills are required to achieve learning.

“Our research into the learning management system segment reveals a great deal of attention placed on creating, managing and delivering content to students,” said James Wiley, Principal Analyst at Eduventures, the research division of NRCCUA. “While these are vital for promoting student success, institutions must also empower faculty to improve teaching practices and increase their subject–matter expertise ¾ which is enabled through other technologies or activities such as communities of practice. Extending Brightspace into faculty professional development is an innovative step toward helping institutions combine two essential activities in a single solution.”

The capabilities in Brightspace eliminate the need to maintain a separate LMS for faculty development and enable institutions deliver an efficient, integrated approach to faculty development that delivers greater outcomes. In addition, institutions can deliver PD course offerings and packages from other vendors within Brightspace.

Here are the Seven Ways to Support your Faculty Professional Development:

  • New Way to Organize and Track Faculty and Staff Development: With the new Manager Dashboard, launching this spring, leaders can easily manage the enrollment and completion of professional development courses for staff and faculty. Learners and groups can be tagged with flexible attributes such as date hired, department, reporting structure, campus or location. Using those attributes, rules–based assignments can make it easy to automatically assign participants into the right onboarding and ongoing learning. Plus, managers get to see metrics on course completion.
  • Use the Tools You Love: Learning resources can be seamlessly added from numerous sources. Microsoft OneDrive®, Google Drive™, YouTube, Vimeo and TED talks can easily be added with a simple click to Content or the Activity Feed.
  • Go Mobile and Build Content Natively: Use our HTML5 design templates to make all your content mobile friendly, including video. Plus, subject–matter experts and designers can create, drag–and–drop, import and share resources with built–in authoring tools, or import courses and content from other systems.
  • New Ways of Supporting Assessment: PD participants can practise, demonstrate and get feedback on what they've learned using video–based recordings; e.g., interview skills. The system supports making it easy to provide feedback, evaluation rubrics tied to mastery levels, interactive exercises, game–based learning, or traditional assignments and quizzes.
  • Inspire and Reward: Milestone activities and course completion can easily be recognized and rewarded automatically with badges that show up in a learner's profile card. Participants can track and share their success with personalized certificates.
  • Showcase and Share: Participants can discover and learn from their peers by sharing successes and debating new ideas. Participants can connect with course facilitators and each other through online discussions, virtual video–based breakout sessions and activity feeds ¾ a great way to keep employees engaged in the latest developments.
  • Recognize Informal Learning: Capture and reflect on real–world examples of work. Share and enter dialogue with peers and connect formal learning goals to authentic examples.

Complementing these enhanced capabilities in Brightspace, a new service package focused on delivering customized implementation and consulting services will ensure a robust and successful professional development experience for your faculty.

“We know Brightspace is already being used for professional learning with many D2L clients. After listening to them, we knew we could help find a better way to build a great professional learning experience for leaders,” said John Baker, President and CEO of D2L. “Plus, instructors and staff can use the same learning system to develop their professional skills that their learners are using – which saves organizations money, resources, budget and time.”

D2L's Professional Development Offering for Higher Education supports institutions in addressing their professional development needs, helping to reduce turnover, increase engagement and improve productivity – all in one platform. For more information please visit www.D2L.com.

ABOUT BRIGHTSPACE
Brightspace is a cloud–based learning platform that makes online and blended learning easy, flexible and smart. Brightspace is a quantum leap beyond traditional Learning Management Systems (LMS) – it is easy to drag–and–drop content to create engaging courses, supports all mobile devices, has industry–leading up–time and is accessible for all learners. Plus, Brightspace enables the future of learning with a gaming engine, adaptive learning, video management, intelligent agents, templated interactives for course design, full support for outcomes or competency–based learning, and actionable learning analytics.

D2L's Brightspace was recently named the #1 LMS in Higher Ed by Ovum Research and #1 in Adaptive Learning by eLearning Magazine. In addition, Aragon Research included D2L in its highly coveted Hot Vendors In Learning list.

ABOUT D2L
D2L believes learning is the foundation upon which all progress and achievement rests. Working closely with clients, D2L has transformed the way millions of people learn online and in the classroom. Learn more about D2L for schools, higher education and businesses at www.D2L.com.

Twitter: @D2L © 2018 D2L Corporation

The D2L family of companies includes D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd, and D2L Brasil Soluções de Tecnologia para Educação Ltda.

All D2L marks are trademarks of D2L Corporation. Please visit D2L.com/trademarks for a list of D2L marks.

Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE, MA—(Marketwired – April 09, 2018) –

  • HC Wainwright Global Life Sciences Conference – 2018, Monaco
  • AACR Annual Meeting 2018, Chicago, Illinois, United States
  • 13th edition of the European Smallcap Event, Paris, France

Oryzon Genomics (ISIN Code: ES0167733015) (MAD: ORY), a public clinical–stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences.

Dr. Tamara Maes, Oryzon's Vice President and CSO, will present additional preclinical data of ORY–1001 at the AACR Annual Meeting 2018 to be held 14–18 April at the McCormick Place North/South, Chicago, Illinois, USA. See more info at http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136

Dr. Carlos Buesa, Oryzon's CEO will present the recent progresses of ORY–2001 at the HC Wainwright Global Life Sciences Conference – 2018, to be held at Le Meridien Beach Plaza Hotel, Monte Carlo April 8–10. The Company presentation will take place on Tuesday, Apr 10 at 11:05–11:30 AM in Salon Atlantic–W (2nd Floor).

In addition, Dr. Buesa will present the recent progresses of the company at the 13th edition of the European Smallcap Event to be held in Paris on April 16&17 at The Westin Paris — Vendôme Hotel.

The company has recently reported that ORY–2001 has been approved to start its second Phase IIa clinical trial, this time in mild to moderate Alzheimer's patients. ORY–2001 exerts a holistic action in the different alterations seen in patients with AD and other neurodegenerative disorders. Different experiments suggest that ORY–2001 may act as a disease modifying drug. In AD patients and other neurodegenerative disorders, cognitive deterioration is often accompanied by episodes of agitation, aggression, psychosis, apathy and depression. In preclinical studies, ORY–2001 not only restores memory but reduces the exacerbated aggressiveness of SAMP8 mice, a model for accelerated aging and Alzheimer's disease, to normal levels and also reduces social avoidance in rat models maintained in isolation. The drug has been tested in 6 month rat and 9 month dog GLP toxicology studies to enable long term Phase II studies. The safety and tolerability of ORY–2001 has been studied in a Phase I clinical trial with 106 young and elderly healthy volunteers, confirmed LSD1 target engagement and ORY–2001 brain penetration, and allowed to establish the doses for the Phase II dose finding studies in patients. The company recently started a Phase IIa with ORY–2001 in patients with multiple sclerosis which is currently progressing after the FPI was enrolled in January.

ORY–2001 is an orally administered, brain penetrant drug that selectively inhibits LSD1 and MAOB. The molecule acts on several levels, reduces cognitive impairment, memory loss and neuroinflammation, and at the same time exerts neuroprotective effects. In several preclinical models of MS, ORY–2001 exhibits strong and durable efficacy. LSD1 is an epigenetic modulator, which regulates histone methylation and modulates gene expression patterns. Epigenetic approaches to modify the progression of various neurodegenerative diseases, which focus on the production of changes in gene expression patterns in brain cells, have generated interest in the pharmaceutical industry.

About Oryzon

Founded in 2000 in Barcelona, Spain, Oryzon (ISIN Code: ES0167733015) is a clinical stage biopharmaceutical company considered as the European champion in Epigenetics. The company has one of the strongest portfolios in the field. Oryzon's LSD1 program has resulted in + 20 patent families and has rendered two compounds in clinical trials. In addition, Oryzon has ongoing programs for developing inhibitors against other epigenetic targets. The company has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurodegenerative diseases. Oryzon's strategy is to develop first in class compounds against novel epigenetic targets through Phase II clinical trials, at which point it is decided on a case by–case basis to either keep the development in–house or to partner or outlicense the compound for late stage development and commercialization. The company has offices in Spain and USA. For more information, visit www.oryzon.com.

FORWARD–LOOKING STATEMENTS

This communication contains forward–looking information and statements about Oryzon Genomics, S.A., including financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, capital expenditures, synergies, products and services, and statements regarding future performance. Forward–looking statements are statements that are not historical facts and are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates” and similar expressions. Although Oryzon Genomics, S.A. believes that the expectations reflected in such forward–looking statements are reasonable, investors and holders of Oryzon Genomics, S.A. shares are cautioned that forward–looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Oryzon Genomics, S.A., that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward–looking information and statements. These risks and uncertainties include those discussed or identified in the documents sent by Oryzon Genomics, S.A. to the Comisión Nacional del Mercado de Valores, which are accessible to the public. Forward–looking statements are not guarantees of future performance. The auditors of Oryzon Genomics, S.A, have not reviewed them. You are cautioned not to place undue reliance on the forward–looking statements, which speak only as of the date they were made. All subsequent oral or written forward–looking statements attributable to Oryzon Genomics, S.A. or any of its members, directors, officers, employees or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. All forward–looking statements included herein are based on information available to Oryzon Genomics, S.A. on the date hereof. Except as required by applicable law, Oryzon Genomics, S.A. does not undertake any obligation to publicly update or revise any forward–looking statements, whether as a result of new information, future events or otherwise. This press release is not an offer of securities for sale in the United States. The Company's securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of the Company's securities to be made in the United States will be made by means of a prospectus that may be obtained from the Company or the selling security holder, as applicable, that will contain detailed information about the Company and management, as well as financial statements.

MagneGas Expands into Pasco County, Florida

TAMPA, FL—(Marketwired – April 09, 2018) – MagneGas Corporation (“MagneGas” or the “Company”) (NASDAQ: MNGA), a leading clean technology company in the renewable resources and environmental solutions industries, announced today that it will be opening a new industrial gas and welding supply location to serve the northern Tampa and Pasco County markets in Florida. This will be the 10th location owned and operated by MagneGas across Florida, Louisiana, Texas and California.

“We are excited to launch yet another new location to serve our growing customer base,” commented Ermanno Santilli, CEO of MagneGas. “Our sales team has done an excellent job winning market share in Pascoe County and northern Tampa, using MagneGas2® to open doors and establish new relationships. In addition, this move will make it possible to quickly expand several of our largest client relationships, as they have sizable operations further north along the Gulf Coast that will be better served through our expansion.”

“This new branch is a good example of how we are able to grow quickly and profitably,” commented Scott Mahoney, CFO of MagneGas. “We set a sales budget for this market at the end of 2017, with a plan to build a client base, and then add a location by the end of the second quarter. We have witnessed excellent sales growth results in this market, and we are almost a full 90 days ahead of plan. We are now able to quickly launch this location, knowing that it will be profitable from the first day we open our doors in Pasco County.”

About MagneGas Corporation

MagneGas® Corporation (MNGA) owns a patented process that converts various renewables and liquid wastes into MagneGas fuels. These fuels can be used as an alternative to natural gas or for metal cutting. The Company's testing has shown that its metal cutting fuel “MagneGas2®” is faster, cleaner and more productive than other alternatives on the market. It is also cost effective and safe to use with little changeover costs. The Company currently sells MagneGas2® into the metal working market as a replacement to acetylene.

The Company also sells equipment for the sterilization of bio–contaminated liquid waste for various industrial and agricultural markets. In addition, the Company is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co–combustion of hydrocarbon fuels and other advanced applications. For more information on MagneGas®, please visit the Company's website at http://www.MagneGas.com.

The Company distributes MagneGas2® through Independent Distributors in the U.S and through its wholly owned distributors, ESSI, Green Arc Supply, and Complete Welding of San Diego. ESSI has 3 locations in Florida, Green Arc 2 locations in Texas and one location in Louisiana, and Complete Welding has one location in southern California. For more information on ESSI, please visit the company's website at http://www.weldingsupplytampa.com.

FORWARD–LOOKING STATEMENTS

This press release contains forward–looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward–looking statements. You should not place undue reliance on forward–looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward–looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward–looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward–looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.